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genitor cells provides opportunity to restore life-
sustaining blood and marrow function, and more
importantly, rebuild immunologic competence to pro-
tect transplant recipients from infection and harness
the immunologic antineoplastic potency of an alloge-
neic graft. Although allografts from related donors
were first tested beginning over 40 years ago, only 20
years have passed since the National Marrow Donor
Program (NMDP) initiated the organized multisite
approach to searching and identifying donors for un-
related allogeneic hematopoietic cell transplantation.
This exciting altruistic experiment has helped thou-
sands of potential recipients of which over 30,000
have received transplants, currently more than 3500
each year. These collective efforts, which include
transplant centers to identify the need, and donor cen-
ters to recruit, tissue type, educate, track, and commu-
nicate with nearly 10 million donors, as well as develop
guidelines for their safety and protection, have been
a collaborative and complex success.
Directed from the NMDPCoordinating Center in
Minneapolis, the NMDP personnel assist patients
with their concerns, personal and financial stressors,
and help transplant centers with the logistics of search,
the complexities of the immunogenetics, and provide
guidance to find the best donor for each searching
patient. The NMDP and the Donor Center Network
focus efforts toward careful and noncoercive donor
recruitment as well as establishing procedures to max-
imize donor safety and maintain the effectiveness of
this complex, multi-institutional collaboration.
In this volume we review the 20-year history of
this magnificent human experiment, combining the
best of science and translational medicine with theanonymous generosity representing the best of hu-
man charity and spirit. We present papers outlining
an overview of the NMDP and the growth in trans-
plant activity over the 2 decades of experience fol-
lowed by a detailed description of transplant
outcomes for both adults and children. Details of
growth in donor activity, collections, and trends in
donation experience over time are followed by a de-
tailed assessment of health outcomes in donors that
verify the relative safety and prompt recovery most
donors experience.
Finally, advances in HLA typing technology,
scientific understanding, and tools to ensure the best
donor selection are presented. Despite the incredible
polymorphism of the HLA complex, the opportunity
to search among millions of potential donors has pro-
vided impetus to improve international cooperation in
finding the best donor for each patient. The NMDP’s
efforts to bring expertise and logistics to donor search-
ing has brought new advances to the field and gener-
ated guidelines to improve transplant outcome.
As patients and their donors are brought together,
their physicians, care providers, laboratory scientists,
donor center personnel, community recruiters and
the millions of volunteer potential donors who built
the Network should feel immense pride in all these
accomplishments. We celebrate these experiences and
anticipate new successes for the future to give more
patients another chance for recovery.
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